Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

IDX/DVLA stock hub

IDX/DVLA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

IDX/DVLAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.8T

Indonesia Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

IDX/DVLA

In the news

Latest news · IDX/DVLA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 9.4P50 14.4P75 23.9

Trailing P/E12.8

P25 11.5P50 23.8P75 52.6

ROE9.2

P25 0.6P50 5.1P75 12.2

ROIC12.4

P25 1.3P50 6P75 11.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All IDX/DVLA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

240

Groups with data

Currency

IDR

Showing 240 of 240 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Indonesia
Country code	ID
Employees	1,351
Employees Change	56%
Employees Change Percent	4.32
Enterprise value	IDR 1.3T
Exchange	Indonesia Stock Exchange
Financial currency	IDR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	ID1000117203
Last refreshed	2026-05-10
Market cap	IDR 1.8T
Price	IDR 1,610
Price currency	IDR
Rev Per Employee	1,689,308,050.33x
Sector	Healthcare
Sic	2834
Symbol	idx/DVLA
Website	https://www.darya-varia.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	7.79%
EV Earnings	9.52x
EV/EBIT	7.26x
EV/EBITDA	5.18x
EV/FCF	7.43x
EV/Sales	0.59x
FCF yield	9.97%
P/B ratio	1.18x
P/E ratio	12.84x
P/S ratio	0.79x
PE Ratio10 Y	15.3x
PE Ratio3 Y	13.81x
PE Ratio5 Y	17.83x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	8.06%
EBITDA Margin	11.3%
FCF margin	7.88%
Gross margin	52.6%
Gross Profit	IDR 1.2T
Gross Profit Growth	7.11%
Gross Profit Growth Q	-2.26%
Gross Profit Growth3 Y	9.62%
Gross Profit Growth5 Y	4.99%
Net Income	IDR 140.4B
Net Income Growth	-16.2%
Net Income Growth Q	-29.87%
Net Income Growth Years	2%
Net Income Growth3 Y	24.2%
Net Income Growth5 Y	-5.52%
Pretax Margin	8.27%
Profit Margin	6.15%
Profit Per Employee	IDR 103.9M
Profitable Years	17
ROA	4.69
Roa5y	5.91
ROCE	10.6
ROE	9.18
Roe5y	10.81
ROIC	12.41
Roic5y	13.99

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	5.95%
Cagr15y	6.45%
Cagr1y	3.5%
Cagr20y	10.03%
Cagr3y	0.1%
Cagr5y	-1.94%
Div CAGR10	4.43%
Div CAGR3	-2.35%
Div CAGR5	0.19%
EPS Growth	-16.2
EPS Growth Q	-29.87
EPS Growth Years	2
EPS Growth3 Y	24.2
EPS Growth5 Y	-5.52
FCF Growth	-15.31%
FCF Growth Q	222.72%
FCF Growth3 Y	41.77%
FCF Growth5 Y	12.94%
OCF Growth	-7.69%
OCF Growth Q	137.82%
OCF Growth10 Y	4.28%
OCF Growth3 Y	29.04%
OCF Growth5 Y	9.55%
Revenue Growth	8.7x
Revenue Growth Q	9.28x
Revenue Growth Quarters	3x
Revenue Growth Years	2x
Revenue Growth3 Y	8.56x
Revenue Growth5 Y	4.47x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	IDR 0.93
Assets	IDR 2.5T
Cash	IDR 467.1B
Current Assets	IDR 1.8T
Current Liabilities	IDR 780.9B
Debt	IDR 163.4M
Debt EBITDA	IDR 0
Debt Equity	IDR 0
Debt FCF	IDR 0
Equity	IDR 1.5T
Interest Coverage	7,608.1
Liabilities	IDR 982.1B
Long Term Assets	IDR 684.9B
Long Term Liabilities	IDR 201.1B
Net Cash	IDR 466.9B
Net Cash By Market Cap	IDR 25.89
Net Cash Growth	17.33%
Net Debt EBITDA	IDR -1.81
Net Debt Equity	IDR -0.3
Net Debt FCF	IDR -2.6
Tangible Book Value	IDR 1.5T
Tangible Book Value Per Share	IDR 1,332
WACC	3.67

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.34
Inventory Turnover	2.46
Net Working Capital	IDR 583.4B
Quick ratio	1.67
Working Capital	IDR 1.1T
Working Capital Turnover	IDR 2.19

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	IDR 108
Dividend Years	18
Dividend Yield	6.71%
Last Dividend	IDR 41
Payout Frequency	Semi-Annual
Payout Ratio	86.16%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	78.22%
1Y total return	3.5%
200-day SMA	1,643.2
3Y total return	0.29%
50-day SMA	1,611.9
50-day SMA vs 200-day SMA	50under200
5Y total return	-9.31%
All Time High	4,175
All Time High Change	-61.44%
All Time High Date	2013-06-03
All Time Low	50
All Time Low Change	3,120%
All Time Low Date	1998-09-21
ATR	14.68
Beta	-0.11
Beta1y	0.07
Beta2y	0.12
Ch YTD	-2.42
High	1,610
High52	1,750
High52 Date	2025-05-26
High52ch	-8%
Low	1,595
Low52	1,525
Low52 Date	2025-09-04
Low52ch	5.57%
Ma50ch	-0.12%
Price vs 200-day SMA	-2.02%
RSI	54.67
RSI Monthly	43.85
RSI Weekly	44.3
Sharpe ratio	0.73x
Sortino ratio	1.77
Total Return	6.71%
Tr YTD	-2.42
Tr15y	155.26%
Tr1m	0.31%
Tr1w	0.94%
Tr3m	-4.17%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	IDR 184B
Operating Income Growth	-14.28
Operating Income Growth Q	-30.7
Operating Income Growth3 Y	24.35
Operating Income Growth5 Y	-5.31
Operating margin	8.06

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	88,262,688%
Net Borrowing	-391,916,000
Shares Out	1,120,000,000
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	IDR 179.8B
Average Volume	18,865x
Bv Per Share	1,369.8
CAPEX	IDR -104.8B
Ch10y	7.33
Ch15y	34.17
Ch1m	0.31
Ch1w	0.94
Ch1y	-3.01
Ch20y	203.8
Ch3m	-4.17
Ch3y	-17.44
Ch5y	-31.78
Ch6m	-2.72
Change	0.31%
Change From Open	0.31
Close	1,605
Days Gap	0
Depreciation Amortization	73,917,858,000
Dollar Volume	73,577,000
Earnings Date	2026-07-28
EBIT	IDR 184B
EBITDA	IDR 257.9B
EPS	IDR 125
F Score	5
FCF	IDR 179.8B
FCF EV Yield	13.45x
FCF Per Share	IDR 161
Financing CF	-121,351,916,000
Fiscal Year End	December
Founded	1,976
Goodwill	10,279,461,000
Graham Number	1965.49922
Graham Upside	22.08
Income Tax	IDR 48.4B
Investing CF	-98,220,276,000
Is Primary Listing	1
Last Earnings Date	2025-10-27
Last Report Date	2026-03-31
Last Split Date	2010-11-12
Last Split Type	Forward
Lynch Fair Value	IDR 627
Lynch Upside	-61.07
Ma150	1,638.3
Ma150ch	-1.73%
Ma20	1,602.8
Ma20ch	0.45%
Net CF	68,198,055,000
Next Earnings Date	2026-07-28
Open	1,605
P FCF Ratio	10.03
P OCF Ratio	6.34
Payment Date	2025-11-17
Position In Range	100
Ppne	514,607,435,000
Price Date	2026-05-08
Price EBITDA	IDR 6.99
Ptbv Ratio	1.21
Relative Volume	2.5x
Revenue	2,282,255,176,000x
Tax By Revenue	2.12x
Tax Rate	25.63%
Tr20y	576.14%
Tr6m	-2.72%
Volume	45,700
Z Score	3.48

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

IDX/DVLA dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+6.7%

$108 annual per share

Payout ratio

+86.2%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+0.2%

0 consecutive years of growth

Total shareholder yield

+6.7%

Dividend yield + buyback yield combined

Performance

IDX/DVLA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Technical

IDX/DVLA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

54.7

Neutral momentum band

Price vs 200-day MA

-2.0%

50/200-day relationship not available

Beta (5Y)

-0.11

Less volatile than the market

Sharpe ratio

0.73

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About IDX/DVLA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current idx/DVLA stock rating?

idx/DVLA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full idx/DVLA analysis?

The full report lives at /stocks/idx/DVLA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for idx/DVLA?

The latest report frames idx/DVLA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the idx/DVLA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.